Pfizer CEO ‘hoping’ for ease of ‘once-a-year’ Covid-19 vaccine, says repeated boosters ‘not a good scenario’

Get the latest BPR news delivered free to your inbox daily. SIGN UP HERE


CEO Albert Bourla of Pfizer, an American pharmaceutical company that’s reportedly earning $1,000/second from its coronavirus vaccine, is rather fond of the idea of the world population being forever pharmaceutically immunized from the coronavirus.

In an exclusive interview Saturday with an Israeli news publisher, Bourla said he’s “hoping” to vaccinate the world from COVID annually, as reported by Reuters.

“What I’m hoping [is] that we will have a vaccine that you will have to do once a year. Once a year it is easier to convince people to do it. It is easier for people to remember. From a public health situation, it is an ideal solution,” he said.

“We are looking to see if we can create a vaccine that covers Omicron and doesn’t forget the other variants. And that could be a solution unless something completely different comes out.”

It’s easier, he argued, than giving out booster shots every couple of months. It may also be more profitable.

According to CDC data, only 83.6 million Americans have received a booster shot, whereas 210 million have been “fully vaccinated” with either one dose of the Johnson & Johnson vaccine or two doses of the other vaccines, including Pfizer.

(Source: CDC)

Either way, Pfizer is set to earn an incredible amount of money.

This, critics say, is no coincidence.

Look:

A press release published by the international charity group Oxfam in November revealed that Pfizer, BioNTech and Modern were “making combined profits of $65,000 every minute,” which comes out to over $1,000 per second.

This was relevant to the charity organization because the pharmaceutical giants had (and reportedly still are) providing vaccines primarily to the “rich countries” that could afford it.

“These companies have sold the majority of doses to rich countries, leaving low-income countries out in the cold. Pfizer and BioNTech have delivered less than one percent of their total vaccine supplies to low-income countries, while Moderna has delivered just 0.2 percent. Meanwhile 98 percent of people in low income countries have not been fully vaccinated,” according to the press release.

The release included a quote from Maaza Seyoum, a member of the African Alliance and People’s Vaccine Alliance Africa.

“It is obscene that just a few companies are making millions of dollars in profit every single hour, while just two percent of people in low-income countries have been fully vaccinated against coronavirus,” the quote reads.

“Pfizer, BioNTech and Moderna have used their monopolies to prioritise the most profitable contracts with the richest governments, leaving low income countries out in the cold.”

A similar argument has been made about the booster shots. The World Health Organization actually advises against booster shots, on the grounds that the Western countries buying them up to boost their own populace should instead give them to third world nations where the majority of the populace aren’t even vaccinated.

Yet the Biden administration and the Democrat Party at large have chosen to align themselves with the pharmaceutical giants.

Critics say this too isn’t a coincidence:

In fact, these critics appear to even include the writers at Jacobin, a self-styled socialist magazine.

“The House Democrats Bought and Paid For by Big Pharma,” a title of a piece published in September reads.

Oof …

DONATE TO BIZPAC REVIEW

Please help us! If you are fed up with letting radical big tech execs, phony fact-checkers, tyrannical liberals and a lying mainstream media have unprecedented power over your news please consider making a donation to BPR to help us fight them. Now is the time. Truth has never been more critical!

Success! Thank you for donating. Please share BPR content to help combat the lies.
Vivek Saxena

Comment

PLEASE JOIN OUR NEW COMMENT SYSTEM! We love hearing from our readers and invite you to join us for feedback and great conversation. If you've commented with us before, we'll need you to re-input your email address for this. The public will not see it and we do not share it.

Subscribe
Notify of
0 Comments
Inline Feedbacks
View all comments

Latest Articles